EMMA NICOLLI: Open Payments
NPI 1548008345 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 44 payments from 28 companies in 2025. Trend: 2023 $0 · 2024 $793 · 2025 $1,097
Food & beverage: $1,097
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 4 | $188 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Merck Sharp & Dohme LLC | 3 | $68 |
| GENZYME CORPORATION | 3 | $67 |
| PFIZER INC. | 3 | $61 |
| GlaxoSmithKline, LLC. | 2 | $51 |
| ABBVIE INC. | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Agios Pharmaceuticals, Inc. | 1 | $40 |
| ARRAY BIOPHARMA INC | 2 | $37 |
Products named: RYBREVANT, KEYTRUDA, SARCLISA, Venclexta, IBRANCE, PYRUKYND, Enhertu, XALKORI.
Industry payments across OR — which companies pay providers there.
